Best Anabolic Steroids

Press Enter to search the full catalog.

US Domestic discreet shipping
Third-party batch tested
HPLC & MS verified purity
Trusted Anabolic Manufacturers Only
US Domestic discreet shipping
Third-party batch tested
HPLC & MS verified purity
Trusted Anabolic Manufacturers Only
Back to all products
GHK-Cu 50 mg Copper Tripeptide - Axiolabs

Axiolabs

GHK-Cu 50 mg Copper Tripeptide - Axiolabs

Injection · 50mg · vial

Out of stock
CompoundGHK-Cu copper peptide
ClassResearch peptide
Half-lifeNot established
DetectionNot on WADA list
Liver toxicityLow
Water retentionNone
A 50 mg vial of a copper-binding tripeptide that occurs naturally in plasma and saliva. Mixed with bacteriostatic water, the solution takes on the blue-green colour of the copper complex. Most published work is on skin cells, wound models and topical application, and no human pharmacokinetic profile has been established.
GHK-Cu 50 mg Copper Tripeptide - Axiolabs
Order Now, Ships Today
Quality First

All products are manufactured under strict quality standards and independently tested before release. By purchasing, the buyer agrees to use these products in compliance with all applicable laws.

Buy GHK-Cu 50 mg by Axiolabs at Best Anabolic Steroids. The vial holds 50 mg of the copper tripeptide complex as a lyophilised powder: three amino acids, glycine, histidine and lysine, bound one to one with a copper ion. It is mixed with bacteriostatic water before use, and the concentrate is deep blue-green because of that copper.

It is a research material rather than a medicine. Copper peptides are best documented in skin biology and in experimental wound models, and the reference sheets for this catalogue state plainly that no human half-life, no validated human dose and no human safety file exist for the vial on this page.

Product Overview

The peptide was first isolated from human plasma and later found in saliva and urine, where it appears to serve as a copper carrier. In laboratory work on fibroblasts it is associated with collagen and glycosaminoglycan synthesis, antioxidant activity and an anti-inflammatory effect, and copper itself is a cofactor in enzymes involved in connective tissue maintenance.

Two limitations follow from that evidence base. The first is route: almost everything published concerns topical application or cell cultures, while injection data in humans are absent. The second is pharmacokinetics. No human elimination half-life exists, so any dosing discussion is arithmetic on a label rather than modelling of a curve. On the competitive side the substance was not found in the WADA prohibited list, though that is an absence of a finding rather than a licence to use it.

Dosage Protocol

Nothing about this peptide is approved, so the figures below are laboratory and vendor reference points. With a 50 mg vial the arithmetic is straightforward, and it is worth writing the numbers down before the first draw.

Reconstitution 2-5 ml of bacteriostatic water in the 50 mg vial, giving roughly 10-25 mg per ml depending on the volume chosen
Research reference Around 1-2 mg daily has been used in models; this is a laboratory figure, not a human dose
Duration Determined by the study design; no validated human course length is published
Women No separate female protocol appears in the sources; nothing is confirmed
Route Topical application dominates the literature; subcutaneous use in humans is not documented

Working with a 50 mg vial

Five millilitres of water in a 50 mg vial yields 10 mg per ml, so 0.1 ml carries 1 mg and reads as 10 units on a U-100 syringe. Two millilitres yields 25 mg per ml, which triples every draw for the same reading on the barrel. Copper is the reason the solution looks the way it does, and it is also the reason a vial should not be treated casually by anyone who reacts badly to the metal.

Suggested Protocols

Practical use clusters into short, exploratory blocks rather than long schedules, and the mixed vial is the part that needs discipline. Because the peptide is not hormonal, there is no cycle stacking logic to follow, and the same vial supports skin-focused work or experimental systemic use without any change to its handling.

Copper peptide block
GHK-Cu - from the mixed 50 mg vial + Bacteriostatic water and the Axiolabs research range
Short blocks only; the sources give no validated duration for repeated use

Where the vial is used alongside a training plan that already includes hormones, the hormonal side is planned separately: a base such as Testaplex P 100 on its own injection rhythm, Arimiplex held in reserve for a genuinely high estradiol reading, and Exeplex as the second option when an inhibitor is warranted in a longer block. The peptide itself does not interact with any of them.

What to Expect

  • Timelines in people are unknown. Wound contraction and faster healing are model findings; the reference material lists no human schedule at all.
  • Skin cells respond in culture. Fibroblast studies describe more collagen and more glycosaminoglycan, which is the biological basis usually quoted for cosmetic interest.
  • Topical work is the bulk of the data. Anything injected is extrapolation from topical and laboratory findings rather than a tested route.
  • The copper colour is expected. A blue-green tint after mixing means the complex is intact, not that the product has spoiled.
  • Sterility is entirely on the user. A research vial carries no guarantee of dose accuracy beyond the supplier label.
  • Cold chain matters more than dose tinkering. A warm or repeatedly thawed solution is the most common way to waste a vial like this.

Side Effects and Management

Injection site reactionsRotate the site and use clean technique. Human data are too limited for a meaningful frequency.
Topical irritationStop applying and watch the skin if it reacts. Uncommon, and usually confined to the site.
Copper hypersensitivityDo not use it if copper has caused a reaction before. A theoretical concern with any copper complex.
Allergic responseStop immediately and seek medical help for signs of a systemic reaction. Rare but the reason to start small.
No defined human side effect profileKeep blocks short and log every use. The sources list no human profile to work from.

After the Course and Follow-Up

No post-cycle therapy is needed, and there is no hormonal reason to plan one. The tripeptide does not touch the gonadal axis, so testosterone production continues as before, and the only follow-up worth doing concerns the mixed vial and the condition of the skin or site being studied.

At the endFinish the planned block and pause; validated repeat-use schedules do not exist in the sources
Mixed vialRefrigerate and use within the vendor window; the exact shelf life of our particular vial is not confirmed
PowderKeep cold and dark before mixing, and avoid freezing the lyophilised material
ObservationTrack appearance of the skin or the injection site; there are no laboratory markers specific to this peptide
DisclosureMention the peptide to any clinician treating a skin or wound problem, since interaction data are absent

Anti-estrogens such as Tamoxiplex 20 and Clomiplex 50, and growth hormone support such as AxoTropin, belong to other plans in the same catalogue and are listed with everything else in the Axiolabs range on Best Anabolic Steroids.

This page is educational and laboratory reference material. The Axiolabs GHK-Cu vial is presented as research-grade material supplied for experimental work, not as a drug and not as a treatment for any medical condition. The amount figures restate vendor and laboratory reference data for the peptide rather than a clinical recommendation. Nothing here should be taken as medical advice. Keep the products away from children and follow local regulations.
What is GHK-Cu?
A three amino acid peptide, glycine-histidine-lysine, bound to a copper ion. It was first isolated from human plasma and is studied mainly in skin biology and wound healing. The Axiolabs vial carries 50 mg of the complex as a lyophilised powder for laboratory work, not as a licensed medicine.
What is GHK-Cu used for in research?
Collagen and glycosaminoglycan synthesis in fibroblast cultures, antioxidant activity, anti-inflammatory signalling and wound models are the recurring themes. Almost all of it is in vitro or topical, which is why the honest summary is skin and connective tissue interest rather than a systemic treatment claim.
What is the half-life of GHK-Cu?
Not established. The reference material says so directly, which means every dosing decision is made from a supplier guide rather than from pharmacokinetics. It also explains why nobody can give a detection window for the compound: without human kinetics there is no curve to describe.
How do you reconstitute a 50 mg GHK-Cu vial?
Add bacteriostatic water slowly down the wall of the vial and swirl rather than shake it. Two to five millilitres give about 10-25 mg per ml, so the same draw on the syringe means very different amounts depending on the volume chosen. Write the concentration on the vial before storing it.
Why is the mixed solution blue-green?
That colour is the copper in the complex. The peptide binds one copper ion per molecule, and copper salts in solution are blue to green. A clear or colourless solution after mixing would be the surprising result, not the blue-green one.
Is topical or injected GHK-Cu better studied?
Topical by a wide margin. Skin preparations dominate the literature, while human subcutaneous use has essentially no published data. That gap is the reason this card does not pretend to describe a validated injection protocol for people.
What are the main side effects, and is GHK-Cu banned in sport?
Local site or skin reactions are the expected events, with copper sensitivity as the specific caution; a serious allergic reaction means stopping at once. The substance was not found on the prohibited list, but an absence in the list is not the same as a ruling that it may be used.
How should the 50 mg vial be stored, and is it FDA approved?
Keep the lyophilised powder cold, dark and unfrozen; once mixed, hold it in the fridge and use it inside the vendor window, which is not a regulator standard. Approval is a no: no regulator has licensed GHK-Cu as an injectable medicine, and this vial is sold as research material.

No reviews yet

Be the first to share your experience with GHK-Cu 50 mg Copper Tripeptide - Axiolabs

Log in to write a review

Complete the protocol

Stack it with

View all →
Added to cart